>> just holding on the top line. >> and with the stock chart, too. it looks like it's been cut in half, but two companies. >> those shares under pressure after hours. we'll follow the calls and comments for you. thank you for joining me this hour. that does it for "closing bell." "fast money" begins now. >> "fast money" starts right now. live from the nasdaq overlooking new york city's time scare, i'm melissa lee, your trader rs -- tonight on fast, stashing the cash. corporate cash levels are hovering near a record, but which sectors are flush with the most cash to spend? we've got surprising answers, plus, a nearly $2 million bet that walmart's record run is only just the beginning. we'll take you bethind staggering trade and later, as tim cook celebrates five years in the apple suite, we'll hear from john sculley for his thoughts on cook's tenure and what he sees as the bigs challenges for apple. first, we start off with a story that moved the market.

mylan filing and pushing the nasdaq lower into the close. this is the outrage over the company's price hikes intensifies. for more, let's bring in meg. >> hey, melissa. washington really ratcheted up the pressure on mylan over these epipen increases today. this coming in succession of different areas of the government. hillary clinton putting out a tweet this afternoon saying that epipens can be the difference between life and death. no justification for these price hikes sign iing it h. that means hillary herself was involved in that tweet. then the white house weighing in. john earnest, he responded by saying while they can't second guess mylan, these kinds of price increases can raise moral and ethical questions. >> pharmaceutical companies that often try to portray themselves

as the inventors of life saving medication, often do real damage to their medication by being greedy and jacking up prices in a way that victimizes vulnerable americans. >> finally, a letter being sent from the senate ageing xae xhe to the ceo asking for more information about what went into these price increases and asking for an inperson briefing, we're asking you provide a briefing on the staff on the price of epipen no later than two weeks from today. mylan responding says we've reached out to every member of congress who sent us a letter. we look forward to meeting with them and responding to their questions. not affecting just mylan shares, around 2:0 o p.m0 p.m., that's hillary tweeted. hillary strikes again. >> you mentioned a briefing. does na imply it's a private briefing or could reach the level of a testimony given the controversy that this whole thing has started?

>> right now, it sounds like it's at the information collecting stages, of course, this is same committee that he will hearings focusing on valiant. that's the fear that this could turn into that. >> meg, thank you. all over that story from day one for us. so, is there a fundamental analysis of this stock at this point? can we say this is this part of the business and this stock is worth this and therefore, it's a buying opportunity? is that possible? zpl it's a franchise product that's under assault from generics. it's possible to stay 41.5, 42 bucks. the stock is very attractive. probably buy for a trade at that level, but they raised eye breauxe brow, bad timing. just management's issue. bad decision on them to make the decision to raise this price that much. it is their franchise drug. under assault from generics, so for a trade, i'd buy it at 41,

42. >> the question is, what does this contribute to operating eps. that's really the question. look at 2014, 2015. it's not clear. mylan doesn't provide the this information and to be clear, mylan is not a bio tech company. this is a generics story and this is a bipartisan issue. so, try not to put this on the whole sector. >> i love valuation, fundamentals, that's what i like to use as the tools to figure out what to do, but here, i think the environment for just a political environment is so bad and will be for at least until the election. that i don't know, maybe by going right into the election, but from here, this is a great cause for her. it plays well. i think she's going to do it again and again. >> because it's not a bio tech company. maybe this is worse, there's price gouging at that level on the generics level. >> i'm not here to be a voice on

whether this is good or bad, but people who say this is going to go to specialty pharma, it won't. this is something these -- >> it's one of the top holdings. the actually or the weights. >> let's go back one year. when the bio tech in general was at a high. there was a couple of pillars, obviously a pretty decent environment until hillary and some of these, this bipartisan thing b about pricing became an issue. now we have m&a again, so maybe this is the way you can get some of these names off the map. all you have to do is go back. >> so, the contest is different. >> what i'm saying is that the regulatory thing is going to stick around. m&a is not even really working

for the acquirers. gilead is 52% off its highs. i think there's lower lows. >> more of mylan on the fast line is institutional investors top-ranked analyst. the senior analyst, he's got a hold rating on mylan. thaungs thanks so much for phoning in. at this point, what is your best guess, your best estimate, as to what the impact on mi lar could be if they're forced to roll back not just the epipen price increases, but they have a list of drugs that have seen 400, oo 500% increases this the first half of this year. >> sure, thanks for having me. there's two broad issues. epipen pricing and generic pricing. epipen is not general. headlines are there's a

potential hear ng the work, but if you talk numbers in particular relative to expectations, expectations are that this drug will go down by about 25 to 30% over the next four year, mainly in expectation for a potential generic watch. could that accelerate more? perhaps, but i think mylan is more dependent on it, but having said that, it's still somewhere between 10 and 20%. as it stands currently. and consensus models the drug decline. on the flip side, you asked about generics. just like many of the other companies, there is a subset of the portfolio that has taken unusual increases, so we'll have some of the other big generic companies and those increases sometimes happen when competitors fall off and limiteded supply of a couple of competitors. that side of the equation has started to louosen up. i think there's a more market dynamic that's fixing that portion. but on epipen in particular, fda

has really made mylan is only standing big player in the market and that's not changing anytime soon. >> so, where is it a buy then? sounds like to a degree, you say you know, a competitor is going to come on the market. it's expected that teva's generic version will be approved in 2017. at what value do you see mylan being a buy? >> look, the feedback from the broader institutional investors on this name is ultimately, they are potentially on a track toward something like $6 in earnings next year. so, when everything's said and done, if they really continue to be on the track towards $6, irrespective of the noise around pricing, corporate governorer nance, at some level, that 6 tlrs has a floor. have said said that, having said that, i think given where we are right now, it seems like at least right now, it's trading on incremental news on senator's tweeting or newspaper writing

about tax issues, so there's a lot of noise on it at this full-time and at that point in time, nobody wants to step in, at least that's the feedback i'm hearing. >> is what you are telling people? >> don't step in. >> i'm neutral rated. for compliance reasons, i can't say anything but that. >> say this becomes, this seems to really skr struck quarter in terms of this being a drug that's potentially life saving, found in almost every classroom across america. this is different than a therapeutic, which is for rare disease or a subset of the population. this is for children and it seems like both sides of the aisle are heated up about this and this could go farther than just mylan. >> yeah, this is, look, you're right. this is clearly an issue. clearly been price ins, price has gone up 500% over the last few years, so there's no arguing there. the only thing that i'll add to that is this broader debate.

there's been a a large inkrecre is understood. i think the parts less understood are couple of things. number one, so, fda has rejected one of the networks. they would have launched a potential generic. that got rejected on certain grounds, and fda took out a mylan key competitor in the market. that was a san ta faye product. it's made mylan even stronger than it is, so there's a regulatory element involved and the second element is and i think this is the part that's the least understood. in 2015, mylan took something like a 30% price increase and their volumes grew. something close to 37% or a fraction of that. year over year, but in reality, it only, it was flat that year. in fact, down 2%, meaning the price increases didn't go to mylan in 2015. it went somewhere else. that's the prt of this debate and this is not a mylan specific issue, this is an issue across

many of the drug stocks. who's keeping those rebates. i think that part of the discussion still hasn't come up. my sense is as this conversation goes on on epipen or drugs in the past, this side of the story is oxygen going to get more important. where do the price increases go. they don't go to drug companies. didn't even go to them. >> all right. we hope you'll come back to the show. top-ranked institutional analyst in pharmaceuticals. where do we go from here? it sounds like he's saying that this is going to go much broader inquiry. it's not a mylan specific issue. >> it's not even noesly drugs. i think it goes to the insurers. it goes to so cv is srk, a name i love. i think everyone in that value asks where to do the rebates go. some could xwo there. i think it's broader than that.

and it's still evolving. zpl so, does that make the sell off we saw in health care today down 1 ppt 6% compared to the broader markets. justify. >> no. it doesn't. and in fact, for people complaining about what's going with earnings in general across the corporate, health care is one of the few places we're seeing earnings go, where the multiples with explainable in this environment. to paint everybody with a brush, it's a branded instrument. >> not a generic. zpl but mylan largely is producing generics. this is the important, that's the core of their business and to say that specialty pha ma or some of the bio tech companies are going to get destroyed because of this, that's not the case. >> we've talked about it the past couple of days. there's a conditioning if you will monster investors. they understand the rhetoric, the noise, they've got their head around it. they're buying the dips, not

selling the rallies. is this sector going to pull back another little bit based on this noise gien the fact volume rs so low? >> would you buy -- >> look at -- >> this was a pullback. are you buying? sfwl i think you could see more weakness maybe tomorrow given the fact people are on vacation. desks are light. >> sounded like you lean bullish. >> we had a nice run. that's the health care selecting and a lot of big pharma, johnson & johnson is really heavy in there, too. you have yield, defensive nature. that's the one trading in late june at 70 bucks. when it rally almost 10%. if you get that probably in the low 70s, that's probably a good level and i think umt to be on some of the more defensive things. i think you want to avoid some of the names or etfs. gold hitting a -- logging their worst performance since march 23th. we'll tell you whether our trader rs buying, plus, corporate cash piles are

hovering near record levels. and later, happy five years at the helm. sam cook and to celebrate, we'll hear from john sculley for his take on the past, present and future for all things apple. much more after this.

your business needs better technology to drive better performance. so you need it to be reliable and fast. really fast. introducing the comcast business summer savings event. fast internet speed to drive performance, plus cutting edge wifi for your employees and customers, and voice mobility so your calls find you wherever you are. get some of our most advanced products at a great price with over $500 in savings. call today and ask how to get these savings plus a $250 prepaid card. comcast business. built for business.

welcome back. the latest on hp's earnings, shares moving lower in afterhours trading on disappointing fiscal fourth quarter and full year guidance. though this third quarter earnings beat on both the top and bottom line. on the call that just got underway, hp emphasizing free cash flow and improvements taking about a billion dollars of costs out and the company's move to address customer demand going from transactional, buying something once, to contractual service. the key driver was notebook sales. $4.3 billion. nearly half a billion dollars better thap expected. the ceo saying that the markets remain challenged and that the company has rigor needed to take profitable market share.

though there were no financial updates on 3-d printing, he said it's off to a good start. >> thank you. >> the notebook thing is is interesting. we know apple in july reported that they were up 5%, so i think that people got negative about the pc environment and what the declines were going on year over year, so maybe there's something there. that's not bad for them, but again, printers is pretty heavy in that component. it's cheap stock. i think you want to be in the hpe. >> let's get to our turn of the day now. gold miners, gdx, 7% as gold hits a one-month low. gold and the miners now trading below their 50-day moving average. are we seeing an exit to the trade? >> for the first time since january, so it's significant. this is the break. what's significant to me is how bullish everyone was on gold. this was another one of these consensus trades, i realize this

is easy to be in hindsight. brexit threw 60 to 70 bucks an ounce in gold. i think things get interesting again. look at yield, commodities in gold and dollar specifically and it tells you, it tells me, that the fed is more in play than people think about the market is telling you there's going to be more of a hawkish tone. that bill dudley and stan fisher have started to resognate with investo investors. >> are you say thag the market is not expecting the hike as much. >> the fed is very hawkish in between meetings. we don't trust the fed anymore. i'm say sg that actually, i think the commentary over the last couple of week, the housing data, payroll, we have enough for the fed to come out and feel differently. >> september hike. >> i think, yeah. on the table. i think it is. and i don't know what's pricing in. >> 20 something percent. >> i would say it's higher. >> higher. >> no, i don't think so september. i think it's too difficult to do ahead of the election. probably december. i think they have enough data to

do it in september, but they won't do it ahead of the election. >> but separately as the miner trade did. >> crowd ed trade, i think it's coming off here. gold i think 1280, 1300, probably you see a little support. what's that, 26.5 on etf, so maybe for a trade at that level, i'd buy, i think this product trade is rolling over. >> still ahead, walmart surging more than 17% and why traders are betting $1.7 million that the stock is heading much hire. we'll take you behind that trade later on. here's what else is coming up. ♪ >> oh, yes. we're talking big, fat stacks of money. because corporate cash piles are fast approaching record levels this quarter. and we're telling you which sectors are flush with the most cash right now. plus -- >> the magic man. now, you see me, now you don't. >> and we'd say apple ceo tim cook is quite the magic man as

he celebrates five years at the helm and tonight, former apple ceo john sculley is here to weigh in on cook and give us his insight into apple's future. that's ahead on fast. ♪ we're drowning in information. where, in all of this, is the stuff that matters? the stakes are so high, your finances, your future. how do you solve this? you don't. you partner with a firm that advises governments and the fortune 500, and, can deliver insight person to person, on what matters to you. morgan stanley. don't put off checking out your medicare options until 65. now is a good time to get the ball rolling. medicare only covers about eighty percent of part b medical costs.

the rest is up to you. that's where aarp medicare supplement insurance plans insured by unitedhealthcare insurance company come in. like all standardized medicare supplement insurance plans, they could help save you in out-of-pocket medical costs. taking informed steps really makes a difference later. that's what it means to go long™. call now and request this free decision guide and explore the range of aarp medicare supplement plans. all plans like these let you choose any doctor or hospital that accepts medicare patients. these are the only medicare supplement insurance plans endorsed by aarp. call now and request your free decision guide... and start gathering the information you need to help you go long™. [click] [click]

[click] man: ♪ you're beautiful ♪ i'm coming back [clicking] ♪ back to you welcome back. corporate cash piles are on track to hit record levels this quarter, so which sectors are courting the most? let's go to a man flush with cash. >> i hate to say it, but i'm living the american dream, which means home ownership and a lot of debt, so not sure cash rich

is anywhere close to how i describe myself. but the same can't be said for some of america's biggest companies, many of whom are hording massive amounts of that cash. according to howard at s&p dow jones indices, we're on pace to see record levels of cash and equivalent holdings and a handful of companies to report in 2q and there's $1.3 trillion of cash on the books. big caveat here about the number. it excludes companies in the financial and utility sector, as well as certain transportation related stocks that keep high amount of cash due to just their business needs day-to-day. recordless, you get the picture, we're on pace for record level of cash in s&p. as for the sectors that are the cash richest, technology has the most. health care in second. around 273 billion and consumer discretionary at 147 billion. whether that leads to more m and

ax ak, that remains to be scene and there's a a lot of variables to be scene, like if the cash is here in the u.s. or stored abroad or whoo the interest rate environment is with regard to bow rowing money, credit ratings, that's part of the picture, it may be fair to say corporate america has a good amount of dry powder to work with. >> thank you so much. so, let's get, the these es here is that while they've got a lot of kark, they're going to spend it somehow and could that benefit shareholders. whether it be three buybacks or dividends which we've seen plenty of or by ak wcquisitioac. >> if you want someone food shg smart. other times, you'd rather them spend the money on give iing it back to shareholders because you're afraid they're going to do empire building. i had a company like coors, tons

of cash. really aggressive buyers of their on stock, plus, it helps thot just the stock price, but the eps. what's interest sg that the most cash rich sectors are the ones with the least cap ex requirements. if you look at the energy sector, this has been a big deal and i would argue that oil at 50 bucks is putting a limit on actual oil going much lower because ultimately, these guys would rather fund their dividend than fund new cap. >> the other sector the tech. we know how much cash is there, but it's skewed and it's offshore. this is a really important point. last year at this time, they had $205 principle this cash. this year, they have 230. here's the big thing. their debt has gone from 65 billion do 85 billion, so i don't know how you can have that conversation about not talk about debt. we know the cost of capital is cheap and it makes sense, but for a company like apple that's

not going to deploy, their r and d is so much lower, you say, why. >> still ahead, tesla may be doubling down on its need for speed, but did elon musk just do something that's worrisome for investors? and after the break, making his way onset right now, former an p l ceo in the building here at the nasdaq as we celebrate tim cook's an versesy at the helm. his take on the next iphone, that's next. ♪

[announcer] is it a force of nature? or a sales event? the summer of audi sales event is here. get up to a $5,000 bonus on select audi models.

major major indices ended in the red. health care was the worst performer being weighed down on the market, having its worst day in two months. here's what's coming up. ryan lochte losing all sp sponsorships. the ceo of one of those

companies sits down to talk with us, plus, elon musk is putting his money where his mouth is on the planned acquisition of solarcity, but could it be dangerous for investors? a top shareholder speaks out. first, a key moment in history. five years ago today, an ailing steve jobs stepped down and was replaced by tim cook. since then, apple has amaszed a cash pile of $231 billion. also, the impb 6 and apple watch highlight a few of the innovations that have helped lead to soaring revenues, for more op the future, we are glad to be joined by former apple ceo, john sculley. john, always great to see you. >> thank you, melissa. >> you when you talk about this an versesy, steve jobs and tim cook are inextricably linked. what is your fondest memory? >> my greatest memory is much of what steve ended up doing towards the end of his life was

defined by the ideas that he was explaining to me back in the early part of the personal computer industry, so, the ideas and where it was all going, steve was the only one who saw it as becoming a consumer industry when i came to silicon valley, i was the first consumer person to show up there. everyone thought it was for engineers and for business people. and steve said, no, we're going to make computers for nontechnical people, creative people and he saw the whole thing. we were doing phone prototypes back in 1984, so steve jobs' vision was decades ahead of efb else and we know the results. it's terrific. >> how would you grade his tenure as ceo? >> i would give him an a plus plus. >> really? >> absolutely. tim cook has done i think a terrific job of taking a company that was as much a cult as a culture and scaling it in a very complex industry. remember, apple is the only one

who has the integrate the software and the hardware. so, samsung makes really cool hardware product, but -- apple may have 13% market share, but it's got 94% of the profits of the industry and he's been able to hold on to that profit margin and ipg he's done a perfect job. >> a lot of what the company has been built on has been inpart, a result of steve jobs' vision. so in the next five year, are you confident that that sort of vision exists now at the company in order to keep it going? >> well, i'm not inside out. i haven't been there for a long time, but here's what i think. don't underestimate the power of the ios operating system and loyalty of iphone users. even back in the early '80s, we said we're going to sell to the people who love us, when apple goes through a refresh cycle, it is powerful.

the product may not be as dif rench rating as it used to be, but the reality is there's incredible loyalty in that refresh cycle just going to go on. what they do beyond their current product line, i don't know. don't think this company isn't going to have great performance for years ahead. >> a lot of talk, obviously, it was the five year anniversary of tim cook taking the helm, but a one year an versesy. apple stock was one of the biggest, got destroyed. opened on 10% that day. tim cook sent an interesting precedent this morning. e-mailed jim cramer and said, chain's doing well. that was a great quarter in china that ended in september, but since then, growth rates have deaccelerated. i thought to myself wondering if tomorrow morning, the stock opened 10, 15%, what would tim cook e-mail jim cramer about and

saying going so well thr them. >> the way i think about it is that warren buffett you know, invested $1.5 billion and may invest more. this is a value stock. it's not a growth stock. multiple is around 11, 12, somebody rnd there. look at the multiples for microsoft, more than double that. look at the multiple for amazon, facebook. these are growth stocks and this is not a growth stock. it's not valued on innovation. it's valued on the best product out there and it's got an incredible path of cash flow ahead of it. it's just a different company than it was when steve was running it and it was based on you know, incredible brand-new products than anyone had seen. >> i hear you, it's not based ton multiples are very different for the other company, but do you think that the innovation is still there for them to get the kind of growth they've had in the past? not just the refresh.

>> it's to be seen. i think we don't know yet. they've said publicly they want to move more into services and hugh is work ong that. he's got a very talented team. around him. and that's important. can they turn the services business into a really killer business model? the reality is that television today is over facebook and amazon studio. with over the top. it's not you know, a better user interface for cable tv. which is why i think the problem steve was trying to solve five years ago. so, what is it that they're going to do? will they come out with something as good as alexa? i was amazed it wasn't apple who came out with alexa. it was amazon. my guess is that will be some products that will come out. it's tough when you go into brand-new industries like self-driving cars.

so people going into it. different than what apple's done before and it's a long-term play. these products won't come on the market until several more years. i always wonder whether apple will break steve's rule. tim cook is clearly capable of running big companies, so i always wonder, is there a bigger company out there. >> you wonder and you think they should or shouldn't? >> i think tim cook is totally cape obviousable of running a b business and the culture has now adapted to his leadership. i'm not suggesting they should buy a company. he's fully capable. >> pleasure the to see you. thanks for coming by. former ceo of apple on this an versesy. so, what do you make, can you actually made a significant portfolio change. >> i did. i sold most of our apple and it's a great company. it's been a nice run, but i am concerned that even if we see big numbers coming off you know, the new launch, that the

multiple won't change. and i feel like the downside of things we don't see big numbers. the multiple may change. actually, to the downside, so i'm kind of sad to see it go, but i feel like here, it's sort of in man's deal. >> i think tim's an amazing manager. there's a very big difference between a visionary and a manager and i look at apple, they were the master of the sigmoid curve. going into their next growth cycle just as the one they were in, started to roll over and they kept that going for so long. right now, what's going to get a growth manager to step in and pay? i don't see it. 100, 125. they trade the stock. i think the you can see a ramp in that, which could accelerate the stock through that 125 range, but then, probably sales na that. >> look at samsung. at all time highs. they've been destroy iing it.

been crushing the ball ab i think apple's services business, you could argue disappointing. should be growing more. i think you combine that on the if samsung continues to grow like this, apple will continue to grow. they are hardware companies. >> want to get to workday because it's surging. >> that's right, up about 10% in extended trade. this despite the financial soft pair player posting a wider than expected adjusted loss. third quarter guidance fell short. the overarching concern continues to be around competition from the larger tech players like oracle and sap, but the ceo telling jim cramer brushing off those concerns basically on competition saying quote, we continue to beat sap and oracle fairly handedly in evaluations. he also mentioned a partnership with samsung shares are higher by around 15%. >> thank you so much.

dan, what's your trade? >> this is matszively unprofit bable company on a gap basis. it's got high, short interest. they just missed a guided down and it's trading up. to me, i think this is really important. oracle, who is a big competitor, made a $9.3 million acquisition of net sweep. that's what workday is trading at heigright now. $16 billion market cap. i don't think there's anyone out there who's going to pay a 30% premium for this thing, so you better believe earnings are going to get better, so i just don't see it. >> still ahead, tesla ceo elon musk is doubling down on its deal to buy solarcity by piling millions into its debt, but is the investment too close to home? plus, shares of walmart on a tear. one trader is betting big, but the about to take off to new heights. we'll explain after the break. make them lighter? t the lubricants that improved fuel economy. even technology to make engines more efficient.

what company does all this? exxonmobil, that's who. we're working on all these things to make cars better and use less fuel. helping you save money and reduce emissions. and you thought we just made the gas. energy lives here.

if tesla wants to fight it out as a car company in the electric space, that's what they should focus on. if i wanted to invest, which i haven't, that's what i want to do. now, it's a con vaa lewded story, plus an integration story. >> that was investor, kefren o lorry on halftime report

reacting to the decision to buy most of solarcity's offering as tesla acquires solarcity. musk purchased $65 million worth of debt while the company's ceo and executive peter reed are at 17.5 million each. important to note they are musks cousins. joe, a portfolio manager is not concern ed about the bond boyin. his firm is among tesla's biggest shareholder, owning more than $130 million worth of the stock baseded on teed's close. great to have you with us. >> great. thanks for having me. >> wouldn't you have rather seen musk, an executive is going to make a pufs, shouldn't they by the stock and not the debt? this raise it is question doesn't anybody else want to buy this debt aside from the people who exist at the top? >> i think it's pretty funny. like you said, any other company this happens, any chairman, ceo,

buys the company's stock, buys a bond offering, sends a positive signal. e does it and the shorts come screaming. a sign of insider trading. the whole house of cards is falling down. obviously, he sees value and he's putting his money where his mouth is. >> but wouldn't you want to have some you know, significant institutions rather than 100 of the 24 million being insider ts these guys so see this continue down the road, but if this is an attractive bond offering, wouldn't it be something people step up to the plate for? >> they did 300 million over the past couple of month that is elon was not a part of. >> i guess the go ahead. >> it's karen, hi. why wouldn't they buy some of the debt that's already out there that's trading at a much higher yield?

>> well, we don't -- personal money, his decision. other company, other ceo does it and it's no big deal, a sign of confidence. >> do you guys think it's even better a sip of a greater confidence to the company that these guys are so tied up on every level financially or is that a, obviously, it's not a concern. at what point does it become a concern or is it just irrelevant that this is a largest shareholder in both companies and the guy is coming in buying half the debt offering. we love managers who were the largest shareholders. incentive over the long-term, that's shown to be a good strategy and will continue to be a core piece going forward. long-term managers have a longer term vision. that's what the stocks we want to own. >> thanks a lot for coming on. appreciate it. >> thank you. >> let's trade tesla here.

does this make you think twice? there was a distinction though. between a ceo buying stocks versus buying a bond. >> yeah, i don't know what to read into it. better than buying than selling it. we've seen nders sell things before, so, i don't know what to make of it. >> it's confusing as he can. if i'm a tesla holder, i say you know, it really does take your eye off the ball from the standpoint of what this company is looking to do when they have the insider sort of transaction. if you didn't have the inside ownership in that, i don't think it would be as confusing, so i look at it from the standpoint of the inside ownership of it. why are they buying solarcity? they're looking to getting into the home down the road. maybe it's an investment they want to make now, who knows. but the fact there's inside ownership scares me. >> if there was a default of some kind, if the company went

bankrupt couldn't actually make their obligations, i think we'd have a literal cost upon tesla. i also think we'd have a figurative impact on this, the elon musk kind of aura and i think it's very clear that the vision, which he sees, i get the vision, but do you have to say it was this forced? was it fast forwarded because in fact solarcity needed this investment. >> i would say ultimately, if you go and read the book, wrote this biography on him. this was th guy was on the brink of selling the company three years ago. in may of 10 20 13, this guy goes all in, he's bought on almost every offering. on equity, i mean, honestly, i don't think you can take it too negatively. whether it's solarcity's distraction, i have no idea, but he probably likes having his ducks in a row in one spot. >> all right. still ahead, the parent company of speedo, jeff spoke to cnbc

about dropping ryan lochte as one of the faces of its brand. we'll hear from the ceo, next. plus, what does a trader rally? we'll explain after the break. miles per hour. a0 to win, every millisecond matters. both on the track and thousands of miles away. with the help of at&t, red bull racing can share critical information about every inch of the car from virtually anywhere. brakes are getting warm. confirmed, daniel you need to cool your brakes. understood, brake bias back 2 clicks. giving them the agility to have speed & precision. because no one knows & like at&t.

welcome back to "fast money." shares spiking after reporting earnings. sy ma? >> yeah, another big mover, retailer apparel giant, pvh, raising projections on strong results as international sales helped off set weaker retail demand in the u.s. the company's calvin klein brand reported a 15% increase. pvh is the company of speedo, the ceo just spoke to cnbc about dropping ryan lochte as one of the faces of its brand. >> it wasn't so tough, it was unfornt is the way i would describe it. we can't condone that behavior. what we stand for as a company and brand is too important to us and our consumers look to us, so ryan's been a terrific athlete. he made a mistake, but it was a mistake that a 32-year-old man shouldn't be making.

zpl be sure to catch the full swer interview on "mad money" tonight. back to you. >> thanks so much. anybody got a trade on pvh? >> it's interesting, it is so tied into retailers. the presence there is very important. and like a number of retailers the there, the fear was way overdone. they're great. they run a great business, so i'm getting more positive back to school being really good. i like. >> what do you want to be in the retail ecosystem? do you want the to be with pvh, or the department stores, the ones that here is some video, by the way. >> is the question do i want to be in calvin klein under wear. >> and is sellers. >> i think actually, if you look at macy's, it's been a phenomenal run and probably largely cap. i think nordstroms has more room.

clearly, there's probably a bigger hurdle. pvh has had a phenomenal run. traded down into the 60s, so up almost 85%. i think it's more diversitied. ipod wait for a pullback, but i would own it. >> it's all about what manny says on the call. see what he says. calvin klein improving is important. >> when did you get all those tattoos? >> show that video of me. >> for more on retail, taking a look walmart. bullish bets on the giant. dan nathan has the action. >> it was kind of a quiet day in the options pits, especially as it relate to retail stocks. there was an interesting stock, call volume was 2.5 times average and appeared to be 2 20,000 of the calls basically for pennies. opening buy of 20,000 of the september 72.5 calls paying 89 cents to open. it's that $1.7 million in premium that breaks even at 73.39.

what are the things that's interesting about this owning long premium directional trades like i suppose this is, in an environment we are in a holiday, the stock market is basically not moving. we have labor day coming up. really tough way to make money being long options. i want to make a point. maybe it has to do with this. the stock has just cerecently broke that trend since november, but i don't suspect any ooent ts between now and then. the company's going to have their annual analyst meeting. you see this gap? last early october. it's been working up. it's been a massive outperformer. up 18%. nearly double the performance. so expeck tases are high so, if you are convicted and looking for some more volatility in the broad market or potentially as you head into their analysts meeting, you may want to define

low. i wouldn't be look at september. i'd look out and capture the analyst meeting and possibly, the earnings happening in mid november. >> you were once a shareholder of walmart. >> i don't love the yet deal, but that doesn't really matter. i just think this price, 16.5 times, it's not cheap enough for me. >> these guys had a good quarter for them. there's a lot of optimism. there's a lot of challenges in the second half of the year on margin. spend ago lot of money to get people back. >> check out the full show friday, 5:30 p.m. up next, final strad. stay tuned. i'm here at the td ameritrade trader offices. steve, other than making me move stuff, what are you working on? let me show you. okay. our thinkorswim trading platform aggregates all the options data you need in one place and lets you visualize that information for any options series.

okay, cool. hang on a second. you can even see the anticipated range of a stock expecting earnings. impressive... what's up, tim. td ameritrade.

finlg trade. >> i think you can nibble on barrett here after a huge pullback. >> karen. >> for me, it was selling apple. not sure and i know there will be a lot of tweets, i'm an idiot, but i feel like i just -- >> sliding up right now. >> on fire. >> seller of fin.

we had a report out today downgrading the stock. multiples gone from ten to 15 and it's up 40%. sell the stock here. >> i would not chase it. thanks for watching, see my mission is simple -- to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now! hey, i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends, my job is to save you some money. call me at 1-800-743-cnbc or tweet me @jimcramer. fool me once, shame on you. fool me twice, and i'm an idiot who deserves the heat. that's my